Institutional ticker directory tracking stock mentions, long/short ideas, and high-conviction pitches extracted from quarterly hedge fund letters.
| Ticker | Company | Sector | Industry | Pitches | Stance |
|---|---|---|---|---|---|
| Fund / Manager | Thesis Excerpt | Stance | Period / Date | Action |
|---|---|---|---|---|
Laughing Water Capital Matthew Sweeney | “Avanos was acquired for a 72% premium. In brief, Avanos was a good co / bad co situation, where the good co. operated with ~20% margins as the leading provider of feeding tubes to hospitals and other medical facilities, and the bad co. struggled with profitability while operating in the pain management space. This bad co. obscured the attractiveness of the good company through consolidated financials, but a new CEO had made it clear that he intended to surface this value, which he of course did. Avanos came at a price that I am more happy with.” | BULL | Q2 2026 Jul 17, 2026 | View Pitch |
Summers Value Fund Andrew Summers | “Avanos Medical was acquired for $25 per share, representing a substantial premium and a major gain over the fund's purchase price. The fund's initial thesis was driven by a critical leadership transition and historically low valuations, which aligned with their value investing framework. They plan to retain a minor stake until the transaction officially closes to optimize tax treatment.” | BULL | Q1 2026 Apr 25, 2026 | View Pitch |
Each excerpt above is the manager's commentary on this ticker specifically. The full letter has the rest of their portfolio thinking, risk discussion, and broader institutional context.
